Almirall, S.A. (ALMRY)
OTCMKTS
· Delayed Price · Currency is USD
10.76
+0.90 (9.08%)
At close: Apr 24, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Commercialization through Own Network | 708.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercialization through Own Network Growth | 7.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercialization through Licensees | 88.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Commercialization through Licensees Growth | 1.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Dermatology in the United States | 57.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Dermatology in the United States Growth | -22.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Management and Results Not Assigned to Other Segments | 40.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Management and Results Not Assigned to Other Segments Growth | -9.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research and Development Activity | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research and Development Activity Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Spain | 296.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spain Growth | 8.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany | 217.58M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany Growth | 6.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe and the Middle East | 128.65M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe and the Middle East Growth | 34.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Italy | 74.83M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Italy Growth | 22.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 57.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | -22.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America, Asia and Africa | 48.55M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America, Asia and Africa Growth | -6.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
France | 42.71M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
France Growth | 21.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom | 27.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom Growth | 21.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Management and Revenue Not Allocated to Other Segments | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Corporate Management and Revenue Not Allocated to Other Segments Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|